COPYRIGHT© 2018 吉林紫鑫药业股份有限公司
Announcement of Jilin Zixin Pharmaceutical Co., Ltd. on the Online Attendance Meeting and the 2013 Annual Report
Stock code: 002118 Securities abbreviation: Zixin Pharmaceutical Industry Announcement No.: 2014-013
Jilin Zixin Pharmaceutical Co., Ltd.
Announcement on the holding of the public apology and the 2013 annual report online briefing
The company and all members of the board of directors guarantee that the content of the information disclosure is true, accurate and complete, and there are no false records, misleading statements or major omissions.
Jilin Zixin Pharmaceutical Co., Ltd. (hereinafter referred to as “the company”) received the “Administrative Punishment Decision”  No. 24 of the China Securities Regulatory Commission on February 21, 2014. For details, please refer to the company on February 22, 2014. Announcement on the Administrative Punishment of the China Securities Regulatory Commission.
According to the relevant regulations of the “Guidelines for the Standardized Operation of SME Board Listed Companies of Shenzhen Stock Exchange”, the company will adopt a network to convene a public apology meeting and hold an online briefing session for the 2013 annual report. The specific arrangements are as follows:
1. The company is scheduled to hold a public apology and annual report online briefing on the online platform provided by Shenzhen Securities Information Co., Ltd. from 15:00-17:00 on March 4, 2014 (Tuesday).
2. The public apology meeting and the annual report online meeting will be held in a remote network mode. Investors can participate in the public apology meeting and annual report on the panoramic network investor interactive platform (http://irm.p5w.net). Online briefing session.
3. The attendees of the meeting were: Chairman of the Board of Directors Cao Enhui, Director Zu Chunxiang, Director Yin Jinlong, Independent Director Li Fei, Independent Director Wang Xu, Deputy General Manager Han Ming, Secretary of the Board Zhong Yunxiang and Chief Financial Officer Xu Jifeng.
Investors are welcome to participate actively!
Jilin Zixin Pharmaceutical Co., Ltd. Board of Directors
February 25, 2014